Trial Details

Recruiting
Basic Information
Clinical ID c5016
Identifier ISRCTN14296856
Trial Title A randomized, placebo-controlled, double-blind, multi-center study to evaluate efficacy and safety of oral BT-11 in mild to moderate ulcerative colitis
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions Ulcerative colitis Digestive System Ulcerative colitis
Interventions A total of 195 subjects with mild to moderate UC (total Mayo Score 4-10; MES 2:2) are planned to be enrolled into this study from approximately 46 centers in Europe and the United States. Eligible subjects will be randomized in a 1:1:1 ratio to receive BT
Participant Information
Sponsor Landos Biopharma Inc.
City NULL
Country/Region Belarus;Bosnia and Herzegovina;Croatia;Georgia;Hungary;Moldova;Poland;Russia;Serbia;Ukraine;United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type Interventional
Phase PHASE2
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL